Acter Group Co., Ltd. (will be abbreviated “Acter” in the after, stock code: 5536) announced the revenue for July 2022. On a consolidated basis, revenue for July 2022 is NTD 2.8 billion, and the revenue has an increase of 81 percent compared to the same period of last year which amounted to NTD 1.55 billion. Revenue for the first seven months of 2022 is NTD 14.7 billion, which is a significant increase of 39 percent compared to the same period of last year and renews the history of new records.

Acter indicates that the monthly revenue has two consecutively increases and renews the new high record. It benefits from the Group enhanced to expand the take order momentum of multi-industries, push the order backlogs stably remains the history new high level, and stably push up the completed project amounts of the Group’s orders of cleanroom and electromechanical engineering projects. On the other hand, Acter keeps a double-digit percent monthly revenue growth except April’s China covid lockdown deferred the project revenue recognition. It shows that Acter’s multi-industries, multi-regions, and the multi-type of engineering work strategies implement successfully satisfy the factory process order and excellent quality demand from the multi-industries clients, create the Group’s overall market competitive advantage, and create the overall operation continue to grow.

Acter further indicates although the main enterprises of the cleanroom industry were affected by the shortage of the labor resource and shortage of material, defer the new factory expansion plan, Acter’s current processing projects schedule is still unaffected and in good condition, and Acter’s business scope widely included the cleanroom, the high-tech electronic, the green energy optoelectronics, the data center, the biotechnology medical, and the traditional industries. The Group steadily increases the professional engineers and has nearly 1,800 employees. The employee region proportions are 45%, 45%, and 10% for the Taiwan, China, and Southeast areas, respectively. Acter continues to deepen the talents developed, to increase the integration ability and high-reliability process quality of the large scale turnkey project, aggressively deem the growth foundation for the middle and long term operation, and help the overall operation stably grow.

Acter is expected to change the share par value from NTD 10 to NTD 5, the last trading date for the old shares is September 6, the trading suspension period of original shares is from September 7 to September 16, TPEx listing and trading date for the new shares is September 19. Unaffected by the original shareholders’ equity, it’s expected to increase the outstanding shares and reduce the share trading cost, and share the operation result with the investors.

Outlook the third quarter of 2022, Acter’s order backlogs remain at the high level so far, deem the good future growth for the middle term and long term operation, through the intelligence production, flexible arrangement of project engineers, implementation of vertical and horizontal resource integration, satisfy the clients’ delivery schedule and the control of the cost and the expense. Besides, Acter strengthens to expand the overall take order momentum, gradually show the synergy of the multi-districts sale territory, diverse industries take orders, professional process method combined with introducing the green technology application, and deepen the synergy of the Group and the subsidiaries, overall to increase the Group’s competitive advantage and create the future’s operation to step forward.

*The number is unaudited.

Acter 2022/07 Concise Consolidated Revenue Report：                                   

Unit: NTD thousand；%

News Contact:

Acter Assistant Vice President  Miss Tsao  (04)2261-5288  IR@acter.com.tw